Status:
UNKNOWN
Influenza Vaccination in Patients With Scleroderma
Lead Sponsor:
Tel-Aviv Sourasky Medical Center
Conditions:
Influenza Vaccine in Scleroderma
Eligibility:
All Genders
16-90 years
Phase:
PHASE4
Brief Summary
The safety and efficacy of vaccination against influenza in patients with scleroderma is not clear. The objective of this study is to assess its safety and efficacy in 50 patients with scleroderma in ...
Detailed Description
Fifty patients with scleroderma and 30 healthy , aged matched controls will participate in the study. After signing informed consent, all subjects will be vaccinated with the inactivated split virion...
Eligibility Criteria
Inclusion
- Patients \>18 year old age
- Capable to sign a informed consent
- Suffering from scleroderma
Exclusion
- Known allergy to influenza vaccine
- Allergy to eggs
Key Trial Info
Start Date :
November 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01002508
Start Date
November 1 2009
End Date
March 1 2010
Last Update
October 27 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tel Aviv Medical Center
Tel Aviv, Israel, 64239